Quick Answer
Silence Therapeutics plc reported Total Assets of $131.44 million for the year ending 2025.
- Silence Therapeutics plc showed a decrease of -35.1% in Total Assets from 2024 to 2025.
- This data is from Silence Therapeutics plc's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $185.30 million | Q2 2025: $165.23 million | Q3 2025: $146.79 million.
- Over the full 3 years of available data (2023 to 2025), Silence Therapeutics plc's Total Assets has grown by 10.0%.
- Historical annual values: Fiscal year 2025: $131.44 million | Fiscal year 2024: $202.64 million | Fiscal year 2023: $119.45 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: